Hofseth BioCare ASA's receivables is $43M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (September 2026), HOFBF shows a receivables of $43M. That compares with $22M in the prior-year period — up 95.4% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, HOFBF's receivables is now $43M (was $22M) — a 95.4% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Hofseth BioCare ASA is outperforming or lagging.
Tracking HOFBF's receivables over time shows whether Hofseth BioCare ASA is scaling, shrinking, or reshaping that part of the business. The current reading is $43M That compares with $22M in the prior-year period — up 95.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this receivables page, Stockcircle has Hofseth BioCare ASA's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $43M) with ownership activity and broader fundamentals.